
Company valuation, historical trends, and peer comparisons.
According to Alvotech’s latest financial reports and current stock price. The company's current Enterprise Value is 2.94B. This represents a change of 1.66% compared to the average of 2.89B of the last 4 quarters.
The mean historical Enterprise Value of Alvotech over the last ten years is 2.23B. The current 2.94B Enterprise Value has changed 31.56% with respect to the historical average. Over the past ten years (40 quarters), ALVO's Enterprise Value was at its highest in in the December 2024 quarter at 5.13B. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.
Average
2.23B
Median
2.71B
Minimum
0
Maximum
4.68B
Discovering the peaks and valleys of Alvotech Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 4.68B
Minimum Annual Increase = -42.16%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 2.71B | -42.16% |
| 2024 | 4.68B | 27.50% |
| 2023 | 3.67B | 35.25% |
| 2022 | 2.72B | 217.58% |
| 2021 | 855.18M | -14.04% |
| 2020 | 994.84M | Infinity% |
The current Enterprise Value of Alvotech (ALVO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.69B
5-year avg
2.93B
10-year avg
2.23B
Alvotech’s Enterprise Value is less than Teva Pharmaceutical Industries Limited (61.18B), less than Amgen Inc. (294.71B), less than Biogen Inc. (43.44B), less than Regeneron Pharmaceuticals, Inc. (99.16B), greater than Amphastar Pharmaceuticals, Inc. (1.61B), less than Amneal Pharmaceuticals, Inc. (9.78B), less than Organon & Co. (10.73B), greater than Harrow Health, Inc. (1.28B), greater than Eton Pharmaceuticals, Inc. (1.46B), greater than Collegium Pharmaceutical, Inc. (1.50B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 61.18B | $47.96B | |
| 294.71B | $251.39B | |
| 43.44B | $36.94B | |
| 99.16B | $100.11B | |
| 1.61B | $1.15B | |
| 9.78B | $7.11B | |
| 10.73B | $3.63B | |
| 1.28B | $1.06B | |
| 1.46B | $1.46B | |
| 1.50B | $768.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alvotech using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alvotech or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Alvotech's Enterprise Value?
What is the highest Enterprise Value for Alvotech (ALVO)?
What is the 3-year average Enterprise Value for Alvotech (ALVO)?
What is the 5-year average Enterprise Value for Alvotech (ALVO)?
How does the current Enterprise Value for Alvotech (ALVO) compare to its historical average?